The Stanford Headache Program Publications

Gastric stasis in migraineurs: Etiology, characteristics, and clinical and therapeutic implications.
Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL.
Cephalalgia. 2013 Mar 5. [Epub ahead of print]

Migraine headache is present in the aura phase: a prospective study. Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A. Neurology. 2012 Nov 13;79(20):2044-9. doi: 10.1212/WNL.0b013e3182749eed. Epub 2012 Oct 31. PMID:23115208

Beyond Neurovascular: Migraine as a Dysfunctional Neurolimbic Pain Network.
Maizels M, Aurora S, Heinricher M.
Headache. 2012 Jul 3. doi: 10.1111/j.1526-4610.2012.02209.x. [Epub ahead of print]

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
Ho TW, Pearlman E, Lewis D, Hämäläinen M, Connor K, Michelson D, Zhang Y, Assaid C, Mozley LH, Strickler N, Bachman R, Mahoney E, Lines C, Hewitt DJ; Rizatriptan Protocol 082 Pediatric Migraine Study Group.
Cephalalgia. 2012 Jul;32(10):750-65. Epub 2012 Jun 18.

Migraine with persistent visual aura.
Evans RW, Aurora SK.
Headache. 2012 Mar;52(3):494-501. doi: 10.1111/j.1526-4610.2012.02103.x. No abstract available.

Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.
Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT, Hirtz D; Chronic Migraine Treatment Trial Research Group.
Neurology. 2012 Mar 27;78(13):976-84. doi: 10.1212/WNL.0b013e31824d5846. Epub 2012 Feb 29.

Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
Ho TW, Ho AP, Chaitman BR, Johnson C, Mathew NT, Kost J, Fan X, Aurora SK, Brandes JL, Fei K, Beebe L, Lines C, Krucoff MW.
Headache. 2012 Feb;52(2):224-35. doi: 10.1111/j.1526-4610.2011.02052.x. Epub 2012 Jan 6.

Chronic migraine: a road less travelled.
Aurora SK.
Headache. 2011 Nov-Dec;51(10):1578. doi: 10.1111/j.1526-4610.2011.02023.x. No abstract available.

Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
Rothrock JF, Cady RK, Aurora SK, Brandes JL, Myers JA, Fox AW, Farr SJ.
Curr Med Res Opin. 2011 Nov;27(11):2185-91. doi: 10.1185/03007995.2011.619177. Epub 2011 Sep 26.

OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.
Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.

Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK, Aurora SK, Brandes JL, Rothrock JF, Myers JA, Fox AW, Farr SJ.
Headache. 2011 Sep;51(8):1202-11. doi: 10.1111/j.1526-4610.2011.01972.x. Epub 2011 Aug 3.

Implications of current clinical trials focused on medication overuse and therapeutic prophylaxis.
Aurora SK.
Headache. 2011 Jul-Aug;51 Suppl 2:93-100. doi: 10.1111/j.1526-4610.2011.01956.x.

Decoding chronic migraine: translating clinical trial data into optimal outcomes with novel therapies.
Aurora SK.
Headache. 2011 Jul-Aug;51 Suppl 2:76. doi: 10.1111/j.1526-4610.2011.01953.x. No abstract available.

Trimester-specific blood pressure levels and hypertensive disorders among pregnant migraineurs.
Williams MA, Peterlin BL, Gelaye B, Enquobahrie DA, Miller RS, Aurora SK.
Headache. 2011 Nov-Dec;51(10):1468-82. doi: 10.1111/j.1526-4610.2011.01961.x. Epub 2011 Jul 28.

OnabotulinumtoxinA for treatment of chronic migraine: a response.
Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF.
Headache. 2011 Jun;51(6):1005-8. doi: 10.1111/j.1526-4610.2011.01925.x. Epub 2011 May 17. No abstract available.

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
Aurora S, Diener HC, Dodick D; PREEMPT Chronic Migraine Study Group.
J Headache Pain. 2011 Apr;12(2):137-8. doi: 10.1007/s10194-011-0334-4. Epub 2011 Apr 3. No abstract available.

Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a case-control study.
Fonteh AN, Pogoda JM, Chung R, Cowan RP, Harrington MG.
J Headache Pain. 2013 Jul 4;14(1):60. doi: 10.1186/1129-2377-14-60.
PMID:23826990  Free PMC Article

Cerebrospinal fluid phospholipase C activity increases in migraine.
Fonteh AN, Chung R, Sharma TL, Fisher RD, Pogoda JM, Cowan R, Harrington MG.
Cephalalgia. 2011 Mar;31(4):456-62. doi: 10.1177/0333102410383589. Epub 2010 Oct 11.

Capillary endothelial Na(+), K(+), ATPase transporter homeostasis and a new theory for migraine pathophysiology.
Harrington MG, Fonteh AN, Arakaki X, Cowan RP, Ecke LE, Foster H, Hühmer AF, Biringer RG.
Headache. 2010 Mar;50(3):459-78. doi: 10.1111/j.1526-4610.2009.01551.x. Epub 2009 Oct 21. Review.
PMID: 19845787

The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid.
Harrington MG, Fonteh AN, Oborina E, Liao P, Cowan RP, McComb G, Chavez JN, Rush J, Biringer RG, Hühmer AF.
Cerebrospinal Fluid Res. 2009 Sep 7;6:10. doi: 10.1186/1743-8454-6-10.
PMID: 19735572 Free PMC Article

Cerebrospinal fluid sodium increases in migraine.
Harrington MG, Fonteh AN, Cowan RP, Perrine K, Pogoda JM, Biringer RG, Hühmer AF.
Headache. 2006 Jul-Aug;46(7):1128-35.
PMID: 16866716